Tyas Rahmah Kusuma

Tyas Rahmah Kusuma

Auto-generated profile, based on publicly available information

Tyas Rahmah Kusuma

Indonesia Medical Education and Research Institute (IMERI), Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2025 in Reproduction, Fertility and Development
Verified
Journal Article
Closed access
PDF file
BWBudi Wiweko
Budi Wiweko
NSNormalina Sandora
Normalina Sandora
RMR R Muharam
R R Muharam
AHAchmad Kemal Harzif
Achmad Kemal Harzif
TKTyas Rahmah Kusuma
Tyas Rahmah Kusuma
AHAndon Hestiantoro
Andon Hestiantoro
Context: Thin endometrium with Asherman’s syndrome is a challenge in in vitro fertilisation, as patients cannot conceive even if the embryo is well. Aims: This study aimed to regenerate thin endometria unresponsive to treatments, using autologous endometrial cells and acellular amnion bilayer as a womb patch. Methods: This preliminary quasi-experimental study investigated thin endometria before and after intervention with an amnion bilayer (AB) and AB with self-endometrial cells (AB + Cells). Patients were IVF candidates with oligomenorrhea, endometrial thickness (EMT) < 7 mm, unresponsive towards hormonal treatment, and three courses of platelet-rich plasma applications. Intervention responses were indicated by (i) EMT measurement, (ii) endometrial cell epitopes, (iii) histoarchitecture and immunohistochemistry, and (iv) relative expression of the endometrial receptivity genes. Key results: Average EMT increased significantly from 5.03 ± 0.95 mm to 6.75 ± 1.39 mm after AB, and further to 7.33 ± 1.92 mm after AB + Cells. Cell density was significantly higher after AB + Cells. The histoarchitecture after AB + Cells developed into a complex tubular system, and E-cadherin and oestrogen receptor alpha (ER-α) was detected. Homeobox A10 (HOXA10) expression increased significantly, up to 4.5-fold after AB + Cells treatment compared with before treatment (P = 0.01), while leukaemia inhibitory factor (LIF) and osteopontin (SPP1) levels also increased, but not significantly. Significant changes in gene expression and cell populations were observed, with improvements in receptivity genes. Conclusions: Patients with thin endometria showed improvement in EMT, histoarchitecture, and receptivity genes after AB and AB + Cells intervention. Implications: The study demonstrates the potential of using a 3D amnion bilayer scaffold with endometrial cells to improve endometrial regeneration.

29 September 2025 in Jurnal Plastik Rekonstruksi
Verified
Journal Article
Open access
PDF file
NSNormalina Sandora
Normalina Sandora
NFNur Amalina Fitria
Nur Amalina Fitria
AWAditya Wardhana
Aditya Wardhana
NPNandita Melati Putri
Nandita Melati Putri
ASAkhmad Noviandi Syarif
Akhmad Noviandi Syarif
BKBenati Karimah
Benati Karimah
Background: The human skin envelops the entire body surface and is highly susceptible to damage. Partial- and full-thickness skin loss often necessitates the use of skin substitutes. Autologous grafting remains the gold standard for skin replacement. Furthermore, the application is usually constrained by the limited availability of donor skin, the technical challenges of surgery, and the added difficulties encountered in severe cases. In this systematic review, we summarise the strengths and limitations of biological and synthetic biomaterials as skin substitutes, with evidence drawn from clinical practice, human trials, and preclinical animal studies. This systematic review evaluates the advantages and disadvantages of biological and synthetic biomaterials used as skin substitutes, drawing evidence from clinical practice, human studies, and animal studies.”Method: We performed a comprehensive literature review using the search engines OVID, ScienceDirect, Google Scholar, and PubMed databases. Search terms or keywords included "artificial skin," "biomaterials," "skin substitute," "full-thickness burn," "synthetic materials," "burn graft materials," and "wound care." From an initial pool of 97 articles, 65 met the inclusion criteria, which required peer-reviewed studies published in English after 2000, focusing on biomaterials for skin substitutes evaluated in clinical, human, or animal studies.Results: Skin substitutes commercially available in the market were predominantly incorporated with human fibroblasts and keratinocytes within a three-dimensional matrix, with a preference for biological materials due to their biocompatibility. Nevertheless, biological substitutes face challenges such as limited availability, extended production time, high costs, and lack of immediate usability. In contrast, synthetic substitutes are more accessible and scalable but often do not integrate well with the recipient's tissue, which limits their clinical efficacy.Conclusion: While both biological and synthetic artificial skin substitutes are available on the market, none of the current options fully meet the ideal criteria for skin replacement, such as affordability, availability, seamless integration with the surrounding tissue, and the ability to minimise scarring. More research is needed to address these limitations and advance the development of next-generation biomaterials that can effectively replace skin.